» Authors » David M Kleinman

David M Kleinman

Explore the profile of David M Kleinman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 92
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huvard M, Patnaik J, Kleinman D, Preston M, Zacks D, Kocab A, et al.
Transl Vis Sci Technol . 2023 Nov; 12(11):35. PMID: 38019499
Purpose: To evaluate the reliability and reproducibility of visual function assessments for patients with macula-off rhegmatogenous retinal detachment (RRD). Methods: This prospective study included patients with unilateral macula-off RRD of...
2.
Wang F, Sansbury L, Ferrante S, Maiese E, Willson J, Chen C, et al.
J Med Econ . 2022 Jan; 25(1):182-192. PMID: 35023807
Aims: Ocular toxicities are common adverse events (AEs) associated with anticancer agents. There is a paucity of data documenting their impact on patient care. This study assessed the clinical and...
3.
Ho A, Kleinman D, Lum F, Heier J, Lindstrom R, Orr S, et al.
Ophthalmic Surg Lasers Imaging Retina . 2020 Nov; 51(11):633-639. PMID: 33231696
Background And Objective: Clinical trials in neovascular age-related macular degeneration (nAMD) demonstrate that high visual acuity (VA) can be maintained, and low VA can be improved with anti-vascular endothelial growth...
4.
Chen A, Dang S, Chung M, Ramchandran R, Bessette A, DiLoreto D, et al.
Ophthalmol Retina . 2020 Sep; 5(5):450-457. PMID: 32866664
Purpose: To compare the relative number of retinal pixels and retinal area imaged using the Optos P200DTx (Optos PLC) and Zeiss Clarus 500 (Carl Zeiss Meditec AG) ultra-widefield (UWF) fundus...
5.
Balderson D, Cai G, Fries M, Kleinman D, McLaughlin M, Trivedi T, et al.
BMC Ophthalmol . 2015 May; 15:42. PMID: 25928630
Background: This objective of the review and analysis is to demonstrate that acyclovir (ACV) 3% ophthalmic ointment is superior to idoxuridine (IDU) in treating herpetic keratitis (HK) presenting as dendritic...
6.
Gensheimer W, Kleinman D, Gonzalez M, Sobti D, Cooper E, Smits G, et al.
J Ocul Pharmacol Ther . 2012 May; 28(5):473-8. PMID: 22554205
Purpose: To evaluate the effectiveness of glycerin 1% formulated with the novel and proprietary ophthalmic excipient poly(l-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) (Eyeon Particle Sciences LLC) in extending tear film break-up time (TFBUT)...
7.
Ramchandran R, DiLoreto Jr D, Chung M, Kleinman D, Plotnik R, Graman P, et al.
Ophthalmology . 2012 Jan; 119(4):674-81. PMID: 22266108
Purpose: To report the clinical characteristics of infectious endophthalmitis after Boston type I keratoprosthesis (K-Pro) implantation. Design: Retrospective study. Participants: One hundred forty-one adult eyes receiving a K-Pro at a...
8.
Dugel P, Blumenkranz M, Haller J, Williams G, Solley W, Kleinman D, et al.
Ophthalmology . 2011 Nov; 119(1):124-31. PMID: 22115710
Objective: To evaluate the safety and tolerability of a single subconjunctival (SCJ) or intravitreal (IVT) injection of an ophthalmic sirolimus formulation in eyes with diabetic macular edema (DME). Design: Randomized,...
9.
Kim D, Kleinman D, Kanetaka T, Gerritsen M, Nivaggioli T, Weber D, et al.
Microcirculation . 2010 Feb; 17(2):128-36. PMID: 20163539
Objective: To test the hypothesis that rapamycin inhibits induced microvascular hyperpermeability directly in vivo. Methods: Male golden Syrian hamsters (80-120 g) were treated with either rapamycin (at 0.1, 0.5, 2,...
10.
Nia J, Lam W, Kleinman D, Kirby M, Liu E, Eng K
Can J Ophthalmol . 2003 Mar; 38(1):46-51. PMID: 12608517
Background: Patients with sickle cell trait and concomitant systemic disease are known to be at risk for proliferative retinopathy. However, there are reports of retinopathy in patients with sickle cell...